3 seeds and 3 drinks approved by a top US doctor to reduce bloating
Tired of too many ads? go ad free now
Dr. Saurabh Sethi, a California-based gastroenterologist trained at Harvard and Stanford, has shared a list of foods and drinks to relieve bloating.
'Are you struggling with bloating or sluggish digestion? These three seeds can turn your gut health around. I'm a gastroenterologist with training at Harvard and Stanford, and this is what I recommend to a lot of my patients,' he said, in a video shared on Instagram.
Sesame seeds
First on the list is black sesame seeds.
'The fiber in sesame seeds helps promote smooth bowel movements. It also contains magnesium, which relaxes intestinal muscles, improving the movement of food through the GI system,' the gastroenterologist said.
Flax seeds
Yes, flax seeds are more than a nutritional powerhouse. They can also relieve bloating. 'The lignans in flax seeds help balance hormones, and their omega-3 fatty acids reduce gut inflammation, promoting a healthier GI system,' the doctor said.
Chia seeds
(All Images Courtesy: istock)
Chia seeds are superstars in today's nutritional and wellness world. These seeds are not only good for weight loss and heart health, but also promote good digestion. 'These seeds can absorb up to 12 times their weight in water and form a gel-like consistency which can help you get excellent BMs,' he
. Remember to soak them for at least 30 minutes before or overnight. You can mix chia seeds into water, juice, or smoothies for an easy, gut-friendly addition to your diet.
Tired of too many ads? go ad free now
Breakfast drinks that can prevent bloating
The gastroenterologist also
three breakfast drinks to combat bloating and support digestion. These beverages are gentle on the stomach and packed with gut-friendly properties.
Warm ginger tea
(Pic courtesy: iStock)
Ginger has long been celebrated for its anti-inflammatory and digestive benefits. Drinking some warm ginger tea in the morning can soothe the stomach and reduce bloating. 'Warm ginger tea soothes digestion and reduces inflammation,' he said.
Plain kefir
Kefir, which is a fermented dairy drink, is rich in probiotics that support a healthy gut microbiome. Its low lactose content makes it gentle even for those with lactose sensitivity. You can have a small glass of plain kefir for breakfast. This simple drink can help reduce bloating and promote smoother digestion.
Foods you should never have with tea
Warm water with honey, and cinnamon
This simple drink combines the digestive benefits of warm water with the soothing properties of honey and cinnamon. According to Dr. Sethi, this simple drink can boost digestion and calm an irritated gut. All you have to do is stir a teaspoon of honey and a pinch of cinnamon into warm water for a comforting, bloating-relieving beverage.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
44 minutes ago
- The Hindu
JNUSU president hospitalised amid ongoing hunger stir
Jawaharlal Nehru University Students' Union (JNUSU) president Nitish Kumar was hospitalised on Tuesday, the 12th day of an ongoing hunger strike, after he complained of chest pain, JNUSU members said. Students have been on an indefinite hunger strike demanding the reinstatement of the Jawaharlal Nehru University Entrance Examination (JNUEE), which has been replaced with a UGC-NET-based entrance system in recent years. The other demands include increasing the merit-cum-means scholarship and revocation of hostel eviction notices for PhD scholars on academic extension. Mr. Kumar, a member of the Left-affiliated All India Students' Association (AISA), was taken to Safdarjung Hospital. Loni, a JNU student and an AISA activist, who participated in the hunger strike, was also rushed to AIIMS on Tuesday afternoon after she blacked out. Both of them are said to be in stable condition. The JNUSU, in an open letter to the JNU Teachers' Association, stated that 14 students have been on hunger strike. 'Our principal demand is the restoration of the JNUEE. This exam has long ensured that this campus remains accessible to students from diverse backgrounds across the country. Its continuation is essential for safeguarding the inclusive character and academic integrity of JNU,' the letter read.
The Hindu
an hour ago
- The Hindu
Experts call for inclusion of Chronic Kidney Disease in national NCD programme
Hyderabad-based dialysis care network, NephroPlus, has urged policymakers to include Chronic Kidney Disease (CKD) screening in India's flagship National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), as it released a white paper highlighting the rising burden of CKD across India and neighbouring countries. Speaking at a media briefing in Hyderabad on Tuesday, NephroPlus Group CEO Rohit Singh said the findings of the white paper and a large-scale screening initiative make a strong case for integrating CKD testing, particularly serum creatinine and urine albumin-to-creatinine ratio (ACR), into existing government-led screenings for hypertension and diabetes. 'The burden is silent but severe. CKD needs to be part of India's NCD strategy immediately,' he said. The paper is based on data from a kidney health screening campaign conducted in the lead-up to World Kidney Day in March. The campaign spanned 30 locations across India, the Philippines, and Uzbekistan, and covered 12 Indian States. A total of 10,501 persons pledged for kidney health awareness, of whom more than 5,000 underwent free serum creatinine and estimated glomerular filtration rate (eGFR) tests. NephroPlus found that several Indian States reported high prevalence of CKD risk factors. Jharkhand topped the list, followed by Haryana and Uttarakhand, Andhra Pradesh, Bihar, Delhi, Karnataka, Maharashtra, Uttar Pradesh, Telangana, Gujarat and Rajasthan. NephroPlus co-founder Kamal D. Shah stressed the economic and emotional toll of dialysis. 'Dialysis is not just a treatment; it is a lifelong ordeal that drains families physically, emotionally and financially. Our data shows that investing ₹1 in prevention saves ₹10 to ₹15 in future dialysis costs,' he said.
Time of India
2 hours ago
- Time of India
Pharma lobby flags 'cumbersome' export rule, seeks change
New Delhi: A significant dip in exports has prompted pharma lobby groups to raise a demand for changing the centralised no-object certification (NOC) provision for drug exports . The provision, which requires pharma companies to seek an approval from the national regulatory agency of the importing country or an NOC from the Indian regulator for shipments, has resulted in a drop in exports and diverted trade to other nations, industry executives told ET. The issue was raised in a meeting held on Monday at Niti Aayog . "Pharma exports have suffered due to the mismatch or an anomaly in newly introduced regulatory standards by the drug regulatory authority of India," said a person who attended the meeting. In early March, the Drugs Controller General of India (DCGI) updated the export NOC checklist in the wake of events such as the controversy over a Mumbai-based drugmaker allegedly exporting addictive opioid drugs to West African nations such as Ghana and Nigeria. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What the Market May Be Getting Wrong About Nvidia Seeking Alpha Read More Undo However, the stringent norms have started hurting exports, industry insiders said. "Taking approvals from different regulatory bodies has only made the whole process cumbersome," the person cited above said. He noted that medicines are manufactured depending on the patient population construct. Live Events For example, Dolo and other paracetamol tablets are approved in India in strengths of 325mg, 500 mg and 650 mg while in Nigeria, it's approved for a strength of 1,000 mg. To manufacture and export that, Indian drugmakers now require an NOC from Nigerian authorities. The lobby groups have urged the government to review the provision as, according to them, this would divert trade to other nations with less stringent regulations. "Such a condition has imposed an undue burden on Indian exporters, potentially stifling innovation and hindering the export of unapproved/banned products especially for the MSME pharmaceutical sector, which is under tremendous strain with respect to compliance to domestic and international guidelines and trade barriers (tariffs & non-tariffs),' an industry expert said on condition of anonymity. The Niti Aayog had called pharma experts to undertake an analysis of the current state of the industry, to understand the challenges faced by drugmakers and initiatives taken by them to ensure production of safe and effective products. Nikkhil K Masurkar, chief executive of Entod Pharmaceuticals, said the official think tank's call for a quality overhaul is both "timely and necessary." "While India has made remarkable strides as a global pharma hub, maintaining consistent, internationally acceptable quality standards remains a key challenge, especially among MSME companies," he said. "The root of the problem often lies not in intent, but in outdated infrastructure, fragmented regulatory enforcement, and insufficient technical training," Masurkar said. "To produce world-class medicines, we must invest in continuous quality improvement, digitalise compliance systems, and empower our MSME sector with both financial and technical support."
